Crucial role of interleukin-4 in the survival of colon cancer stem cells

被引：87

作者：

Francipane, Maria Giovanna ^{[1
]}

Alea, Mileidys Perez ^{[1
]}

Lombardo, Ylenia ^{[1
]}

Todaro, Matilde ^{[1
]}

Medema, J. P. ^{[2
]}

Stassi, Giorgio ^{[1
]}

机构：

[1] Dept Surg & Oncol Sci, Cellular & Mol Pathophysiol Lab, I-90127 Palermo, Italy

[2] Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol LEXOR, NL-1105 AZ Amsterdam, Netherlands

来源：

CANCER RESEARCH | 2008年 / 68卷 / 11期

关键词：

D O I：

10.1158/0008-5472.CAN-07-6874

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Colon tumors may be maintained by a rare fraction of cancer stem-like cells (CSC) that express the cell surface marker CD133. Self-renewing CSCs exhibit relatively greater resistance to clinical cytotoxic therapies and recent work suggests that this resistance may be mediated in part by an autocrine response to the immune cytokine interleukin 4 (IL-4). Blocking IL-4 signaling can sensitize CSCs to apoptotic stimuli and increase the in vivo efficacy of cytotoxic therapy. These findings suggest that inhibitors of IL-4 signaling may offer a new therapeutic tool in colon carcinoma.

引用

页码：4022 / 4025

页数：4

共 21 条

[1] Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M
Wicha, MS
Benito-Hernandez, A
Morrison, SJ
Clarke, MF
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3983 - 3988
[2] AN INTERLEUKIN-4 (IL-4) MUTANT PROTEIN INHIBITS BOTH IL-4 OR IL-13-INDUCED HUMAN IMMUNOGLOBULIN-G4 (IGG4) AND IGE SYNTHESIS AND B-CELL PROLIFERATION - SUPPORT FOR A COMMON COMPONENT SHARED BY IL-4 AND IL-13 RECEPTORS
AVERSA, G
PUNNONEN, J
COCKS, BG
MALEFYT, RD
VEGA, F
ZURAWSKI, SM
ZURAWSKI, G
DEVRIES, JE
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2213 - 2218
[3] Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, Nick
van Es, Johan H.
Kuipers, Jeroen
Kujala, Pekka
van den Born, Maaike
Cozijnsen, Miranda
Haegebarth, Andrea
Korving, Jeroen
Begthel, Harry
Peters, Peter J.
Clevers, Hans
[J]. NATURE, 2007, 449 (7165) : 1003 - U1
[4] Interleukin-4 receptor in moderate atopic asthma - A phase I/II randomized, placebo-controlled trial
Borish, LC
Nelson, HS
Lanz, MJ
Claussen, L
Whitmore, JB
Agosti, JM
Garrison, L
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (06) : 1816 - 1823
[5] Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
[6] IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins
Conticello, C
Pedini, F
Zeuner, A
Patti, M
Zerilli, M
Stassi, G
Messina, A
Peschle, C
De Maria, R
[J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (09) : 5467 - 5477
[7] Phenotypic characterization of human colorectal cancer stem cells
Dalerba, Piero
Dylla, Scott J.
Park, In-Kyung
Liu, Rui
Wang, Xinhao
Cho, Robert W.
Hoey, Timothy
Gurney, Austin
Huang, Emina H.
Simeone, Diane M.
Shelton, Andrew A.
Parmiani, Giorgio
Castelli, Chiara
Clarke, Michael F.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) : 10158 - 10163
[8] Tumour stem cells and drug resistance
Dean, M
Fojo, T
Bates, S
[J]. NATURE REVIEWS CANCER, 2005, 5 (04) : 275 - 284
[9] A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS
FEARON, ER
VOGELSTEIN, B
[J]. CELL, 1990, 61 (05) : 759 - 767
[10] Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Galon, Jerom
Costes, Anne
Sanchez-Cabo, Fatima
Kirilovsky, Amos
Mlecnik, Bernhard
Lagorce-Pages, Christine
Tosolini, Marie
Camus, Matthieu
Berger, Anne
Wind, Philippe
Zinzindohoue, Franck
Bruneval, Patrick
Cugnenc, Paul-Henri
Trajanoski, Zlatko
Fridman, Wolf-Herman
Pages, Franck
[J]. SCIENCE, 2006, 313 (5795) : 1960 - 1964

← 1 2 3 →